Cargando…
A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells
Gemcitabine is a drug of choice in the treatment of human pancreatic cancer. Chemo-resistance to this drug is common and has been attributed to a variety of distinct mechanisms, involving > 100 genes. A recently developed small-molecule G-quadruplex ligand, the trisubstituted naphthalene diimide...
Autores principales: | Ahmed, Ahmed Abdullah, Marchetti, Chiara, Ohnmacht, Stephan A., Neidle, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376204/ https://www.ncbi.nlm.nih.gov/pubmed/32699225 http://dx.doi.org/10.1038/s41598-020-68944-w |
Ejemplares similares
-
A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer
por: Ohnmacht, Stephan A, et al.
Publicado: (2015) -
A G-Quadruplex-Binding Small Molecule and the HDAC Inhibitor SAHA (Vorinostat) Act Synergistically in Gemcitabine-Sensitive and Resistant Pancreatic Cancer Cells †
por: Ahmed, Ahmed Abdullah, et al.
Publicado: (2020) -
The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer
por: Ahmed, Ahmed A., et al.
Publicado: (2023) -
Xanthene and Xanthone Derivatives as G-Quadruplex Stabilizing Ligands
por: Altieri, Alessandro, et al.
Publicado: (2013) -
Targeting Multiple
Effector Pathways in Pancreatic
Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule
por: Marchetti, Chiara, et al.
Publicado: (2018)